Tecan Trading AG

Company Snapshot

Company Overview

Tecan Trading AG is a provider of automated laboratory instruments and solutions designed to empower professionals in clinical diagnostics, basic and translational research, and drug discovery. The company specializes in developing, manufacturing, and supporting automated workflow solutions. Its Cavro-branded instrument components are highly regarded and widely used by top instrumentation suppliers across multiple fields. Tecan works closely with a broad spectrum of clients, including diagnostic laboratories, pharmaceutical and biotechnology companies, and academic research institutions, to support and advance their scientific goals. Cellular and primary cells act as a central instrument in harnessing cell-derived biomolecules and executing a variety of cell-based assays. Tecan assists with designing modular automation for 2D and 3D cell culture, from cloning to transfection, colony picking, cell-based assays, and with their liquid handling and detection platforms cellular analysis.

Financial Highlights (FY 2023)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

Tecan Trading AG In Reports

Single-Cell Genomics and Proteomics: Emerging Technologies and Markets

BCC Research Report: Dive into Single-Cell Genomics and Proteomics Market estimates, data has been provided for 2021 and 2022 as the historic years, 2023 as the base year, and forecast for 2029.

3D Cell Cultures: Technologies and Global Markets

BCC Research Market Analyst says global market for 3D cell culture is estimated to increase from $4.6 billion in 2023 to reach $14.8 billion by 2028 at a CAGR of 26.5% from 2023 through 2028.

Liquid Handling: Technologies and Global Markets

BCC Research Market Report says global liquid handling technologies market reached $4.2 billion in 2022, should reach $4.5 billion by 2023 and $6.6 billion by 2028 with a CAGR of 7.8%.

Company's Business Segments

  • Life Sciences Business (end-customer business) : This segment directly supplies end users with automated workflow solutions, such as laboratory instruments, software packages, application know-how, services, consumables, and spare parts.
  • Partnering Business (OEM business) : This segment develops and manufactures OEM instruments and components that partner companies distribute under their names.

Applications/End User Industries

  • Healthcare
  • Life Sciences